Evidence map›Paper›PMID 30863461›Full record

ReviewInterventional cardiology (London, England)2019

TAVI for Pure Native Aortic Regurgitation: Are We There Yet?

Eduardo A Arias, Amit Bhan, Zhan Y Lim, Michael Mullen

Open access · goldAbstract readReview
In one paragraph

Review in Interventional cardiology (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Transcatheter Heart Valves with Labelling for Aortic Regurgitation.Interventional cardiology (London, England) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Infective Endocarditis in the Elderly: Challenges and Strategies.Journal of cardiovascular development and disease · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Eduardo A AriasInterventional Cardiology Department, National Institute of Cardiology Ignacio Chávez Mexico City, Mexico.
Amit BhanBarts Heart Centre, St Bartholomew's Hospital London, UK.
Zhan Y LimCardiology Department, Khoo Teck Puat Hospital Singapore.
Michael MullenBarts Heart Centre, St Bartholomew's Hospital London, UK.
St Bartholomew's Hospital · GBInstituto Nacional de Cardiología · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of degenerative aortic stenosis has been transformed by transcatheter aortic valve implantation (TAVI) over the past 10-15 years. The success of various technologies has led operators to attempt to broaden the indications, and many patients with native valve aortic regurgitation have been treated 'off label' with similar techniques. However, the alterations in the structure of the valve complex in pure native aortic regurgitation are distinct to those in degenerative aortic stenosis, and there are unique challenges to be overcome by percutaneous valves. Nevertheless some promise has been shown with both non-dedicated and dedicated devices. In this article, the authors explore some of these challenges and review the current evidence base for TAVI for aortic regurgitation.

Indexed as

Aortic valve stenosisnative aortic valve regurgitationsecond generation TAVI deviceTAVItranscatheter valve interventionsvalvular heart disease

Identifiers

PMID30863461
PMCPMC6406131
OpenAlexW2921276221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.